@TheAFTD

@TheAFTD has been a member of Linktree for 5 years and joined in February 2021. The social media accounts linked to from @TheAFTD are: • Facebook • Instagram • TikTok • YouTube • LinkedIn • Email • Threads • X • Bluesky • Phone • Website Besides social media accounts, theaftd has populated their site with: • Navigating Apathy in FTD • AFTD's Provider Letter • AFTD Blog & Updates • What is FTD? • FTD & Genetics Overview • Newly Diagnosed with FTD • AFTD Support Groups • Comstock Grants • Helpful Resources • Advocacy Action Center • Volunteer Opportunities • Ways to Participate in Research • AFTD Store • Support AFTD's Mission • 'Ask a Genetic Counselor' Webinar on April 14 • Donate to Support AFTD's Mission: 2026 Spring Appeal • AFTD 2026 Education Conference • Donate to Support AFTD's 2026 Education Conference • AFTD 2026 Race Season • AFTD Independent Events • Employment Opportunities • View all AFTD News • FAQs • For Researchers • Get Involved • Austin Marathon 2024 • Los Angeles Marathon 2024 • Fall Appeal 2023 • AFTD News - Volume 20 Issue 3: Fall 2023 • U.S. Justice System Stumbles When Faced with FTD and Other Dementias, Article Finds • RedEye Reviews Charity Fundraiser • Open Hand Foundation Provides AFTD $600K Donation • 2023 Impact Report • Pilot Study Evaluates Virtual Coaching’s Ability to Help FTD Care Partners with Self-Care • Dear HelpLine: Connecting During Facility Visits • FTD Behavior Tracker • Volunteer Update: Hosting a Meet & Greet Event • AFTD Volunteer Highlights Differences Between FTD and Alzheimer’s in Newspaper Article • Partners in FTD Care - 2023 Winter Issue • Tips & Advice: Navigating Apathy in FTD • Passage Bio Announces Hopeful Initial Data from Phase 1/2 Clinical Trial • Gene Therapy for FTD: What Do I Need to Know? • Colfax Marathon 2024 • “We’re Just Regular People with an Illness,” Dementia Advocate with FTD Writes in Essay • AFTD Ambassadors • The Lived Experience of FTD: Grief on the FTD Journey • AFTD and ADDF Extend Treat FTD Fund Program Through 2035 • Dear HelpLine: Dealing With Genetic Uncertainty • With Love 2024 • Become an FTD Research Ambassador • Public Benefits When Notable Names Share Neurological Challenges, UCLA Professor Writes • News Report on Tallahassee Couple’s FTD Journey Highlights Challenges of Misdiagnosis • Researcher Discusses Integrating Genetic Testing Into Routine FTD/ALS Care in Podcast Interview • Tucson, Ariz. Meet & Greet • Memphis, Tenn. Meet & Greet • Roseville, Calif. Meet & Greet • Delray Beach, Flo. Meet & Greet • AFTD 2024 Education Conference • Montana Woman Shares Family's FTD Journey in Interview • UK Researchers Discover How to Block Toxic Protein Associated with FTD and ALS • Treat FTD Grant Recipient Discusses FTD-GRN Gene Therapy in Newspaper Interview • Familial Conference: Uncovering the Genetics of FTD/ALS • Capturing Voices - Considerations When Writing YOUR Book • NY State Senator Michelle Hinchey Introduces Bill to Create State FTD Registry • With Love 2024 - Dianna Smith • What to Look for When Considering Facility Care for a Person with FTD • Kevin Rhodes Shares His Journey with FTD • FDA Grants Breakthrough Therapy Designation to Experimental FTD Therapy • Viewpoints of FTD: Addressing Barriers to Diagnosis, FTD Care, and Research Participation Faced by Black/African Americans | AFTD • Addressing Barriers to Diagnosis, FTD Care, and Research Participation Faced by Black/African Americans • Support AFTD's 2024 Education Conference • With Love 2024 - Michelle Slough • Transposon Announces Results from Phase 2 PSP Trial, Interim Results for Phase 2 FTD/ALS Trial • Magazine Editor Shares Legacy of Beloved Seattle Music Promoter Diagnosed with FTD • AFTD Volunteer Shares Father's FTD Journey to Promote Awareness in News Interviews • Link Between TAF15 Protein & FTD Discovered in UK Study • FTD Care Partner Shares Memories of Her Mother on TikTok • With Love 2024 - Kristen Celusniak • Broadcaster Wendy Williams Diagnosed with FTD • Guest Feature: Somebody's Sister • AFTD CEO Discusses Wendy Williams's FTD Diagnosis • Brain Awareness Week 2024 • Making a Difference: Become an FTD Advocate Webinar • Advocacy Update: Rare Disease Day and FTD • A Note to the AFTD Community about Wendy Williams’s FTD Diagnosis • AFTD Webinar: The Current State of FTD • High-Profile FTD Diagnoses Boost Public Awareness, AFTD Ambassador Says • Dear HelpLine: Looking for Support Options • AFTD Launches Social Media Campaign to #EndDementiaStigma • #EndDementiaStigma Toolkit • Dementia Advocate with FTD Shares Her Perspective on Losing Her Driver's License • The Lived Experience of FTD: Driving and FTD • For Health Professionals • Finding Support and Understanding on the Go with the Hidden Disabilities Sunflower • Perspectives in Research Webinar: Navigating Social and Legal Challenges in Familial FTD • AFTD Partners with ALS Association to Support Advancing Digital Tools • Recent Study Highlights Reliability and Validity of ALLFTD Mobile App for Diagnosis and Research • Researchers Adapt Digital Intervention for Dementia Care Partners for FTD, Other Dementias • Roaming in FTD Has an Underlying Reason, Report Says • Noche de Cine y Charla sobre la Demenciade Inicia Temprano • Dear HelpLine: Hyperorality • Spring Appeal 2024 • AFTD Insights - Spring 2024 • Balancing Safety and Autonomy When Persons Diagnosed Leave the Home • AFTD Ambassador Honors Daughter by Spreading FTD Awareness • Tips & Advice: Roaming & Wandering • Not All Forms of PPA Are FTD, as Recent High-Profile Case Highlights • AFTD In-Person Meet & Greet: Bristol, PA • Unidos en el camino: reunión de personas confrontando la DFT • FTD Advocate Discusses Isolation and Housing Concerns Faced by Family Care Partners • First Participant Treated in AviadoBio Phase 1/2 Clinical Trial • U.K. Researchers to Conduct Nationwide Trial Evaluating Blood Test for Dementia • Case Report Discusses Symptoms & Diagnosis of PSP • Dear HelpLine: Brain Donation • A Fireside Chat with Susan Dickinson & Emma Heming Willis • FTD in the Arts • Lorenzo’s Worldwide Youth Summit • National Meet & Greet for LGBTQ+ Care Partners • New York State Senator Michelle Hinchey Introduces First-in-the-Nation Legislation to Create FTD Research Registry • Study Discovers How Variations in TMEM106B Gene Influence Risk & Severity of FTD • FTD & ALS: A Collaborative Approach to Diagnosis and Care • Passage Bio Highlights Promising Clinical Trial Progress in Quarterly Update • The new FTD Disorders Registry is Now Live! • AFTD's 2024 Driving Hope Golf Tournament (NY) • AFTD's 2024 Driving Hope Golf Tournament (CO) • AFTD Board Member Kristin Holloway Tells Her FTD Story to Self Magazine • Aprinoia Therapeutics Receives Fast Track Designation for PET Tracer Used to Diagnose PSP • AFTD Staff and Emma Heming Willis Commemorate FTD Week Resolution in Calif. • AFTD Joins National Institutes of Health AMP ALS Initiative as Partner • Spencer & Paul's Bike Across America for AFTD! • Transposon Therapeutics Receives Fast Track Designation for PSP Treatment • Biomarkers Consortium Letter of Intent to Qualify FTD Biomarker accepted by FDA • AFTD Volunteer Receives “Visionary of the Year 2024” Award for 40 Years of Advocacy • Study Explores Racial Differences in Clinical Presentation of FTD Symptoms, Disease Severity • AFTD Volunteer Speaks about Trading Career for New “Vocation” as Caregiver • Guidance on Brain Donation • Brain Donation Flyer 2024 • Viewpoints of FTD: Brain Donation • Ways to Give: Recurring Donor Program • World Brain Day 2024 - Brain Donation Webinar • The Lived Experience: Brain Donation • Food for Thought 2024 • Vesper Bio Completes Phase 1 Clinical Trial for Potential Disease Modifying Treatment for FTD-GRN • Delaware Passes Resolution Recognizing FTD Awareness Week 2024 • Advocacy Update: Join AFTD in Advocating for FTD Awareness Week in All 50 States • Insights on Stigma: Seth Stern • British/Dutch Study Discovers Role of ANG Gene Mutations in ALS-FTD • Newly Diagnosed Checklist • Dear HelpLine: Support for Familial & Genetic FTD • Advocate for Awareness: Working with Lawmakers to Highlight FTD • AFTD and ALLFTD Collaborate on Brain Donation Video • Researcher Explains the Role of Genetics in FTD, Discusses Avenues for Treatment • Ways to Give • Donate to Support AFTD's Mission: 2024 Summer Newsletter • ASPIRE-FTD Phase 1/2 Clinical Trial Opens First US Site at Ohio State University • Care Partner Emphasizes the Benefits of Support from Others Who Understand FTD • Passage Bio Receives Positive Feedback from FDA on Expanding Gene Therapy to C9orf72 • Volunteer Update: AFTD Welcomes New AFTD Ambassadors • Opinion Column Highlights Racial Disparities in Dementia Care and Need for Support • AFTD News - Volume 21 Issue 2: Summer 2024 • Philadelphia Marathon 2024 • Finding Answers: FTD Research & You • AFTD Grant Recipient Discuss Gene Therapy for FTD-GRN on Canadian TV • The Doctor Thinks It’s FTD. Now What? • Ways to Participate in FTD Research • Research FAQ's • Planned Giving Opportunities - Jary Larsen • Dear HelpLine: Transitioning to Facility Care • FTD Awareness Week Officially Recognized in Five Additional States • AFTD Brand Influencer Discusses Commitment to Caring • AviadoBio CMO Discusses ASPIRE-FTD Clinical Trial with Neurology Live • Study Investigates Incidence Rates of FTD and Other Young-Onset Dementias in Italy • New AFTD Find Support Page Simplifies Search for Help • AFTD Ambassador Shares Her Story on “All Home Care Matters” Podcast | AFTD • Insights on Stigma: Sandy Howe • AFTD Events - Colorado • The Lived Experience of FTD: Deb Jobe • In Memory of George F. Sidoris: Two Siblings' Labor of Love • Passage Bio Discusses Hope for FTD Drug Development • Medical Technology CEO Discusses Using EEG to Differentiate FTD and Alzheimer’s • Dear HelpLine: Social Security Benefits for People with FTD • Acurastem Receives CIRM Grant for Targeted Therapeutic Program for ALS/FTD • FTD Diagnosis and the Hispanic/Latino Community • Care Partner Learning Series: Navigating Behavioral Variant FTD Symptoms Webinar • World FTD Awareness Week 2024 • Guest Feature: One Woman’s Journey - from Getting Diagnosed to Attempting Suicide to Embracing Life • Support AFTD’s Mission • Study Finds That FTD and ALS Have Similar Cellular and Molecular Characteristics • Psilera Announces Positive Preclinical Data for FTD Intervention Candidate • Food for Thought 2024 - Dawn Kirby • Food For Thought 2024 - Big Time's Chili Contest • AFTD Advocacy Conversations: Area Agencies on Aging and Older Americans Act • Food for Thought 2024 - Heather Sellers • Food for Thought 2024 - Lindsey Hunt • Food for Thought 2024 - Terry Walters • AFTD Ambassador Shares Her Family’s FTD Story with Massachusetts Newspaper | AFTD • Young Woman Tells Her Family’s FTD Story on Philadelphia News Segment • Understanding Ambiguous Loss and Anticipatory Grief • Emma Heming Willis Shares Her FTD Experience and Advocacy Work in “Town & Country” Magazine • AFTD hosts 2024 FTD Research Roundtable Meeting • Care Partner Learning Series: Navigating the Holidays with an FTD Diagnosis • Support for Veterans • Donate to AFTD's Fall Appeal 2024 • National Hospice and Palliative Care Month 2024 • Dear HelpLine: Navigating Travel During the Holidays • AFTD Advocacy: State Resolution Training • AFTD Webinar: Diagnosing Primary Progressive Aphasia • FTD Research 2024: Where We’ve Come From and Where We’re Headed • Young Caregiver Talks About Finding Support Amid FTD Journey on Dementia UK Podcast • GemVax & KAEL Announces Results from Phase 2a Clinical Trial for PSP • Impact Report 2024: Empowered Together to End FTD • Advancing Hope: AFTD Staff Attend NORD Breakthrough Summit in Washington, DC • All in the Family to end FTD: Colonial Electric’s Food for Thought Event Clears More than $1 Million Since Inception • Thanks to Generosity of AFTD Ambassador, Californians Receive Crucial Financial Help • Denali Therapeutics Shares Insight Into Developing Treatments • Persons with FTD Advisory Council Special Article: Holiday Madness • Sponsored Testing Programs; opportunities for no-cost genetic testing • Ferrer Doses First Participant in Phase 2 Study for PSP Treatment • AFTD Care Partner Learning Series Webinar: Navigating the Holidays with an FTD Diagnosis • AFTD Develops New Gene Therapy Resource • National Virtual Meet & Greet - January 6, 2025 • Types of FTD • AviadoBio Shares Hopes for FTD Therapeutic Options • Transposon Presents Results from Successful Phase 2 ALS/FTD Clinical Trial • New York Software Company Awards AFTD Gift to Honor Employee's Late Cousin • AFTD 2025 Education Conference • Article Lists Ways Researchers Can Involve People with Dementia in Identifying Research Priorities • AFTD Attends 2024 Society for Neuroscience Meeting • AFTD Ambassador Advocates on Behalf of the Older Americans Act • Can a Tau PET Tracer Aid FTD Diagnosis? Study Explores How Tracer Performs in Other Tauopathies • AFTD Research Team: A Year in Review • Paving The Path Forward: Advancing AFTD's Public Policy Priorities • Employer Matching Gifts • Help & Hope: The Top Articles of 2024 • Difference Between Clinical Care and Clinical Research • Popular FTD Resources • Linde Jacobs Shares Her Families FTD Journey with the New York Times • With Love 2025 • Denali and Takeda Open FTD-GRN Clinical Trial Site at UPenn • FTD Research '24 - Where We’ve Come From & Where We’re Headed • Ohio Care Partner Shares Story to Help Others on the FTD Journey • Tips & Advice: Incontinence - A Troubling Symptom | AFTD • New AFTD Ambassadors • Extracellular Vesicles in Plasma Could be FTD-ALS Diagnostic Biomarker, Study Finds • Upcoming UCSF Trial to Evaluate Effectiveness of Three Drugs for PSP • Submit your Artwork for FTD in the Arts • Most Asked Areas of Our Website • Walking with Grief: Loss & the FTD Journey • AFTD's 2025 Policy Priorities • In TEDx Talk, Neuroscientist Shares Her Father’s FTD Story and Her Hope for Dementia Research Breakthroughs • AFTD Webinar: Paving the Path Forward -- Advancing AFTD's Public Policy Priorities • Passage Bio Announces Interim Data for UpliFT-D Trial for FTD-GRN • Vesper Bio Clinical Trial for FTD-GTN Enters Phase Ib/IIa • Managing the Emotional Impact of Job Loss in FTD • At the Intersection of FTD and the Law Webinar • Recommended Reading/Viewing • Remember Me Podcast Discusses Grief with AFTD Staff in Recent Episode • Planning for Legal, Financial, and Health Insurance Issues • Home and Community Care Options • FTD Researchers Call for Greater Focus on Diversity to Address Disparities in Care and Research • Register for the AFTD 2025 Education Conference • FTD and Intimacy By Anne Fargusson, RN • H&H Advocacy Update: Protect FTD Research • FTD Research Roundtable • Donate to AFTD's 2025 Education Conference • Our Journey Through FTD and Why I Wrote “Welcome to the Honey B & B” • International Women's Day 2025 • AFTD and You: Partners in Drug Development Webinar • Statement from the AFTD on Disruption of Scientific Research Funding and Activities • Pair of Studies Make Significant Findings in Search for FTD Biomarkers • Study Examines Nature of Criminal Risk Behaviors in Dementia • Webinar Recording of 'At the Intersection of FTD and the Law' • National Doctors' Day 2025 • Support the AFTD-Team - Los Angeles Marathon 2025 • AFTD Joins Nearly 150 Supporters in Letter Urging Congress to Reject Medicaid and SNAP Cuts • Statement from AFTD on the Need for Robust and Consistent Medical Research Funding • “Inside Edition” Highlights Upcoming Documentary About a Family’s FTD Journey • FTD Science Digest • Review Article Explores Lived Experiences of Ceasing Driving Due to Young Onset Dementia • TD 5 Boro Bike Tour 2025 • N.Y. Senator Hinchey Reintroduces Bill to Create State FTD Registry | AFTD • Dear HelpLine: Advanced Care Planning • TD Bank Five Boro Bike Tour • Review Article Explores Lived Experiences of Ceasing Driving Due to Young-Onset Dementia • ABC News Honors AFTD Ambassador Spencer Cline as “Person of the Week” • Amplifying AFTD's Advocacy • Hope Rising Benefit Raises Over $1.9 Million for AFTD’s Mission • Speech Therapy CE Course Features AFTD Ambassador Dawn Ducca • AFTD Webinar: How to Find a Genetic Counselor • Study Evaluates the Efficacy of Nasally Administered Hormone for Apathy in FTD • PPA Telehealth Intervention Gets Positive Results in Phase 2 Clinical Trial • Study Evaluates PET Tracer and Explores How PSP Damages Brain Synapses • AFTD News - Volume 22 Issue 1: Spring 2025 • Genes That Cause FTD • What is apathy? • What is familial FTD? • What is sporadic FTD? • AFTD Webinar - Partners in Drug Development • Hospice Care for FTD • Former Judge Gains Artistic Ability after PPA Diagnosis • The Lived Experience of FTD: Managing Anxiety • FTD and ALS Joint Initiatives • Donate to Support AFTD's Mission • The Latest in FTD Research • Credit for Caring Act of 2025 • Two Drugs Selected for Evaluation in Platform Trial for PSP • AviadoBio Announces Completion of Second Cohort in ASPIRE-FTD Trial at AFTD Education Conference • Coya Therapeutics Reports Positive Interim Results in Clinical Trial for Experimental FTD Therapy | AFTD • Navigating FTD-ALS • Study Identifies Profile of Blood-Based Inflammatory Proteins as Potential FTD Biomarker • The Critical Role of Biomarkers in Diagnosis and Treatment • Booklets on FTD • Matching Gifts • Register for the Speech Language Therapy Webinar • Session Videos Now Available from AFTD's 2025 Education Conference • Emma Heming Willis Honored with Caregiving Award • The GUIDE Model and FTD • Genetic FTD Advocate Linde Jacobs Profiled in CBS Minnesota Segment • AFTD Ambassador Shares Husband’s FTD Journey with West Virginia Newspaper | AFTD • Millennial Whose Father Has PSP Explains the Challenges Faced by Millennial Caregivers • AFTD Medical Advisor Emeritus Virginia Lee Elected to National Academy of Sciences | AFTD • Living Well with an FTD Diagnosis • Former U.S. Rep. Wexton, Living with PSP, Featured in “Brain & Life” Magazine | AFTD • Driving Hope Golf Tournament • British Study Evaluates Ability of Novel Protein Assay to Capture Blood-Based Dementia Biomarkers • Advancing Hope: Blood Test for Diagnosing Alzheimer’s Disease Approved by FDA • Vesper Bio Trial for FTD-GRN Treatment Achieves Enrollment Milestone • Chinese Study Explores the Psychological Well-being and Health of Dementia Caregivers • "Alzheimer's & Dementia" Publishes Summary of AFTD's 2022 Holloway Summit • Protect Vital Medicaid Programs! • Celebrating July 4th with FTD • Food for Thought 2025 • Leonard A. Lauder, 1933-2025 • The Lived Experience of FTD: The Challenges of July Fourth | AFTD • Brain Pathology Consistent with FTD Found in Roughly 35% of Motor Neuron Disease Cases in Recent Study • Promising FTD Gene Therapy from AviadoBio Featured in the UK Guardian | AFTD • Sharing Your Story to Make a Difference: How to Connect with Legislators • Dear HelpLine: Comstock Grants • FTD 101: AFTD 2025 Education Conference • Growing Up with FTD: Young Caregivers on the FTD Journey • Brothers Explain in Podcast How They Live With Gene Linked to FTD • AFTD News - Volume 22 Issue 2: Summer 2025 • Passage Bio Provides Updated Interim Data from UpliFT-D Clinical Trial for FTD-GRN • In Podcast Interview, AFTD Ambassador Shares How He Found Purpose Amid Grief | AFTD • From Symptom Onset to Diagnosis: Improving the FTD Diagnostic Journey • World Brain Day 2025 • PBS Documentary Spotlights FTD Couple to Exemplify U.S. “Caregiving Crisis” | AFTD • Florida Radio Station Spotlights AFTD Ambassador for His Dementia-Care Advocacy | AFTD • Donate to Support AFTD's Mission: 2025 Summer Newsletter • Genetic Counseling and Testing Should Be Offered to Persons Diagnosed with FTD, Experts Argue | AFTD • AviadoBio and Astellas Senior Staff Discuss ASPIRE-FTD Trial in Interview • Altered Production of Certain Protein Groups Identified as Potential Markers of FTLD Severity in Study • AFTD’s 2025-2028 Strategic Plan • Awareness Cards • What About the Kids? • Hope Rising 2025 Keynote Speaker Spencer Cline • Guest Feature: Forget Me Not • AFTD Founder Helen-Ann Comstock, 1933-2025 • Honor Helen-Ann's Legacy • Dear HelpLine: Resources for Genetic FTD • Ferrer PSP Drug Receives Fast Track Designation from U.S. FDA • Leading FTD Expert Dr. Bruce Miller Interviewed on “Big Brains” Podcast • The Lived Experience of FTD: Talk Therapy in FTD - Risks and Benefits • Book About Family’s FTD Journey Helps Raise Funds for AFTD’s Mission | AFTD • Emma Heming Willis Interviewed by Diane Sawyer in Prime-Time Special • Guest Feature: Learning to live with familial FTD • World FTD Awareness Week 2025 • October Webinar - Talking to Family About Genetic FTD Risk • Dear HelpLine: AFTD's Awareness Cards • Emma Heming Willis Shares Family Updates on The Oprah Podcast | AFTD • bit.ly • AFTD Ambassador Julia Pierrat featured in Los Angeles Times • FTD Science Digest - September 2025 • AFTD Ambassador Carrie Edwards donates lottery winnings to AFTD |Lottery Charity Donations • People at Potential Risk of Developing FTD Share Views on Effects of Predictive Biomarker Testing • Dear HelpLine: What Comes After an FTD Diagnosis • Comedian Shares Her FTD Caregiving Journey on Podcast • PSP Diagnostic Checklist • National Estate Planning Awareness Week 2025 • Dr. Laura Podcast Hosts AFTD’s Esther Kane • The Lived Experience of FTD: The Benefits of Pets • The Lived Experience of FTD: Anosognosia • Epilepsy More Common in FTD than Alzheimer’s, Study Finds • AFTD CEO Susan Dickinson to Retire in May 2026; AFTD Board Leading Search for Successor • New York State FTD Registry Bill Signed into Law • Alector Therapeutics Announces Results From Their Phase 3 Clinical Trial Evaluating Latozinemab • Something went wrong • November 2025 Webinar: Supporting FTD Care Partners with Individual Therapy • Amylyx Pharmaceuticals Ends PSP Trial of AMX0035 • Tips & Advice: When "I'm Fine" Isn't Fine - Understanding Anosognosia in FTD | AFTD • Why Advocacy Matters Featuring AFTD's Meghan B. • The State of FTD Research Featuring AFTD's Shana Dodge • Alector Clinical Trial Results Townhall • National Family Caregivers Month 2025 • Ways to Manage Stress of FTD - National Family Caregivers Month 2025 • A Rose with Pink Petals: How FTD Revealed Deb Jobe's Hidden Artist | AFTD • New Recommendation: Expanding Genetic Counseling and Testing for People Diagnosed with FTD | AFTD • Donate to Support AFTD's Mission: 2025 Fall Appeal • Honor Helen-Ann's Legacy Today • AFTD Ambassador and “Protective Mama Bear” Dawn Kirby Interviewed on Podcast • AFTD and ADDF Award $2.5 million to Vesper Biotechnology for Drug VES001 Clinical Trial in FTD | AFTD • Dear HelpLine: Find the Helpers • Vanity Fair Features Soho Sessions AFTD Benefit in Honor of Bruce Willis • Rev. Jesse Jackson, Civil Rights Leader, Diagnosed with PSP • AFTD's 2025 Impact Report • FTD Research 2025: Paving the Path Towards Effective Treatments • AFTD Insights • Finding Your Way Through the Holidays with FTD • Donate to AFTD Giving Tuesday 2025 • Love Will End FTD: Katie Brandt on Caregiving, Loss, and Leading Change | AFTD • AFTD Grantee Leads Basic Science Study Exploring Role of Protein in Tau-Based Disorders like CBD • Bobby Kimball, Toto's Original Lead Singer, Living with FTD • Donate to Support Families Like Jennifer and Jim • How to Explain FTD to Kids & Teens • Dear HelpLine: Sharing the Diagnosis • AFTD CEO Susan Dickinson Featured on Dementia Untangled Podcast • AFTD Welcomes New AFTD Ambassadors • AFTD Director of Research Engagement Shana Dodge Presents at 2025 NORD Breakthrough Summit Lightning Round • AFTD's Awareness Cards • Recommended Reading • The Lived Experience of FTD: “Holiday Hacks” That Can Make the Season More Enjoyable • AFTD Ambassador Carrie Edwards Shares Her Lottery Story on Tamron Hall • From Caregiver to Advocate: One Woman's Mission to Transform FTD Support • Help & Hope: The Top Articles of 2025 • Congratulations to AFTD Research Grant Awardees! • AFTD's Diagnostic Checklist • AFTD’s New Genetic Counseling and Testing Recommendation • AFTD and partners award $2.1 million in first year of new FTD Diagnostic Biomarkers Initiative | AFTD • Our Deepest Gratitude to Dr. Walter Koroshetz • AFTD Advocacy Webinar - January 28 • Hope on the Horizon: Daniel Barvin's Personal Mission to Transform FTD Treatment • From Sean 1.0 to Sean 2.0: One Couple's Journey with FTD • With Love 2026 • Genetic FTD News Drives an Artist to Pick Up Paintbrush Again • Dignity Care as an Essential Dementia Guidepost • Brain Donation is Final Gift of 24-Year-Old Diagnosed with FTD • Understanding the Path to an FTD Diagnosis • AFTD Healthcare Professional Webinar - Feb 12th • Art as Hope: Emma Heming Willis Featured in CNN Segment on FTD In the Arts • The Lived Experience of FTD: FTD in the Arts • FTD Call To Action Featured In Canadian Media • AFTD's Esther Kane and Volunteer Liz Zadnik Interviewed on Podcast • AARP Highlights What FTD Caregivers Need to Know • Introduction to Frontotemporal Dementia (FTD) Biomarkers - Mar 10th • Rev. Jesse Jackson, Diagnosed with PSP, Dies at 84 • When Words Become Hard to Reach: John Corvino's Journey with PPAOS | AFTD • AFTD - The Association for Frontotemporal Degeneration • Dear HelpLine: The Caregiver Mind • Submit Artwork for FTD in the Arts • Running Through It: Mike Brucklier's Marathon Journey • California Senate Health Committee Unanimously Advances Bipartisan Bill to Add FTD to the State’s Neurodegenerative Disease Registry | AFTD • Disinhibition in FTD